| Primary |
| Pneumonia |
50.0% |
| Nasopharyngitis |
25.0% |
| Upper Respiratory Tract Inflammation |
25.0% |
|
| International Normalised Ratio Increased |
100.0% |
|
| Secondary |
| Insomnia |
8.3% |
| Infection Prophylaxis |
7.7% |
| Prophylaxis |
7.7% |
| Extradural Abscess |
7.4% |
| Hepatic Neoplasm Malignant |
7.1% |
| Spondylitis |
6.2% |
| Drug Use For Unknown Indication |
5.9% |
| Hypertension |
5.9% |
| Infection |
5.6% |
| Adjustment Disorder |
4.9% |
| Constipation |
4.0% |
| Pain |
4.0% |
| Pyrexia |
4.0% |
| Renal Transplant |
4.0% |
| Convulsion Prophylaxis |
3.7% |
| Cerebral Infarction |
3.1% |
| Duodenal Ulcer Perforation |
2.8% |
| Sedation |
2.8% |
| Depression |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
|
| Rhabdomyolysis |
11.1% |
| Stevens-johnson Syndrome |
11.1% |
| Drug Eruption |
9.3% |
| Liver Disorder |
7.4% |
| Thirst |
7.4% |
| Hepatic Function Abnormal |
5.6% |
| Mouth Haemorrhage |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Mixed Liver Injury |
3.7% |
| Pneumonia |
3.7% |
| Protein Total Decreased |
3.7% |
| Staphylococcal Infection |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Toxic Skin Eruption |
3.7% |
| Agranulocytosis |
1.9% |
| Erythema |
1.9% |
| Hepatic Enzyme Increased |
1.9% |
| Interstitial Lung Disease |
1.9% |
| Overdose |
1.9% |
|
| Concomitant |
| Infection Prophylaxis |
16.4% |
| Drug Use For Unknown Indication |
12.1% |
| Analgesia |
5.6% |
| Fluid Replacement |
5.6% |
| Constipation |
5.4% |
| Hypertension |
5.2% |
| Prophylaxis |
5.2% |
| Insomnia |
4.8% |
| Wound Complication |
4.3% |
| Anorexia |
4.1% |
| Infection |
4.1% |
| Pyrexia |
4.1% |
| Thrombosis Prophylaxis |
4.0% |
| Spinal Anaesthesia |
3.4% |
| Schizophrenia |
2.9% |
| Asthma |
2.6% |
| Gastrointestinal Stromal Tumour |
2.6% |
| Dermatitis Atopic |
2.5% |
| Gastritis |
2.5% |
| Abdominal Pain |
2.3% |
|
| Liver Injury |
11.8% |
| Pneumonia |
9.2% |
| Sepsis |
8.4% |
| White Blood Cell Count Decreased |
7.6% |
| Renal Impairment |
5.9% |
| Sensory Disturbance |
5.0% |
| Stomatitis |
5.0% |
| Hepatic Function Abnormal |
4.2% |
| Muscular Weakness |
4.2% |
| Platelet Count Decreased |
4.2% |
| Pyrexia |
4.2% |
| Rash |
4.2% |
| Stress |
4.2% |
| Vomiting |
4.2% |
| Drug Exposure During Pregnancy |
3.4% |
| Movement Disorder |
3.4% |
| Speech Disorder |
3.4% |
| Anaphylactoid Reaction |
2.5% |
| Death |
2.5% |
| Pneumonia Aspiration |
2.5% |
|
